glp-1 agonists and pancreatitis Understanding american diabetes association history of
Description
doi: 10.1111/dom.12121
They believed it differed from pancreozymin, another small intestine hormone identified by Ivy in 1928 that was subsequently renamed cholecystokinin (CCK) (Kosaka, Lim)

Dual GIP/GLP-1 Receptor Agonists: New Advances for Treating Type-2 Diabetes

Timper K, del Ro-Martn A, Cremer AL, et al

Actual product packaging may appear differently than shown
